American College of Rheumatology: CMS decision an affront to America's sickest Medicare patients

(American College of Rheumatology) The American College of Rheumatology (ACR) today expressed its extreme disappointment with a new Centers for Medicare and Medicaid Services (CMS) decision to allow Medicare Advantage (MA) plans to implement step therapy for Part B drugs and cross-manage Part B and D drug utilization.